Morgan & Morgan’s securities attorneys are investigating claims of possible securities fraud involving MiMedx Group, Inc. (ticker symbol: MDXG). The Food and Drug Administration (“FDA”) has accused the Georgia-based company of producing certain pharmaceutical products without first obtaining necessary licenses and approval from the FDA.
The securities attorneys at Morgan & Morgan would like to hear from you if you are a MiMedx shareholder who has experienced a financial loss due to the large drop in the company’s share price following the announcement of the alleged FDA violations. To learn more about how you may be able to recover compensation through a class action lawsuit, please fill out our free, no-obligation case review form today.